Isn't home where we all want to be?

Reba here for Realtor.com, the pro's number one most trusted app.

Finding a home is like dating.

You're searching for the one.

With over 500,000 new listings every month, you can find the one today.

Download the realtor.com app because you're nearly home.

Make it real with Realtor.com. Pros number one most trusted app based on

August 2024 proprietary survey. Over 500,000 new listings every month based on average new for sale and

rental listings, February 24 through January 2025. Here's your midday brief for Monday, November 3rd. I'm Zoe Colkin for the Wall Street Journal.

Kimberly Clark has agreed to purchase Kenview for more than $40 billion, combining the maker of

Huggies with the owner of Tylenol and one of the year's largest corporate takeovers.

The cash-and-stock deal will create a company with about $32 billion in annual revenue.

Kimberly Clark, the company behind Kleenex tissues and Cottonell toilet paper, has been lagging

rivals like Procter and Gamble in buying Kenview could help its effort to find growth.

But the combined company would also face headaches. Kenview has been under pressure since President

Trump's warning that the active ingredient in Tylenol is a potential cause of autism.

Pfizer is filing a second lawsuit against Metzara in Novo Nordisk, alleging that the weight

loss drug developers proposed merger violates federal antitrust laws. Fizer says that the acquisition would solidify

OZempic maker Novo Nordisk's market position by eliminating a smaller competitor. Pfizer in September

had reached a deal with Metzara to pay up to $7.3 billion for the small biotech company.

Novo Nordisk last week proposed to buy Metzara for up to $9 billion,

and Metzara said Novo Nordisk's bid was better. Pfizer then sued Novo Nordisk and

...